Epizyme (EPZM) to Ring the NASDAQ Stock Market Closing Bell
8/6/2013 9:14:39 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ADVISORY, Aug. 6, 2013 (GLOBE NEWSWIRE) - What: Epizyme, Inc. [EPZM], a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, will visit the NASDAQ MarketSite in Times Square.
Help employers find you! Check out all the jobs and post your resume.
comments powered by